Determination of atenolol in human plasma using ionic‐liquid‐based ultrasound‐assisted in situ solvent formation microextraction followed by high‐performance liquid chromatography

An efficient analytical method called ionic‐liquid‐based ultrasound‐assisted in situ solvent formation microextraction followed by high‐performance liquid chromatography was developed for the determination of atenolol in human plasma. A hydrophobic ionic liquid (1‐butyl‐3‐methylimidazolium hexafluorophosphate) was formed by the addition of a hydrophilic ionic liquid (1‐butyl‐3‐methylimidazolium tetrafluoroborate) to a sample solution containing an ion‐pairing agent during microextraction. The analyte was extracted into the ionic liquid phase while the microextraction solvent was dispersed throughout the sample by utilizing ultrasound. The sample was then centrifuged, and the extracting phase retracted into the microsyringe and injected to liquid chromatography. After optimization, the calibration curve showed linearity in the range of 2–750 ng/mL with the regression coefficient corresponding to 0.998. The limits of detection (S/N = 3) and quantification (S/N = 10) were 0.5 and 2 ng/mL, respectively. A reasonable relative recovery range of 90–96.7% and satisfactory intra‐assay (4.8–5.1%, n = 6) and interassay (5.0–5.6%, n = 9) precision along with a substantial sample clean‐up demonstrated good performance of the procedure. It was applied for the determination of atenolol in human plasma after oral administration and some pharmacokinetic data were obtained.